Turn Therapeutics Financials - Benzinga

Turn Therapeutics Inc

TTRXNASDAQ

Trade with Public

Trade with Public

$9.80

-0.27-2.68%

At close: Sep 4, 5:00 PM EST

$9.80

N/A

After Hours: Sep 4, 4:00 PM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Stock Report

Turn Therapeutics Financials

Turn Therapeutics (TTRX) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Turn Therapeutics Q2 EPS $(0.20) Misses $(0.02) Estimate

Benzinga Newsdesk

PRO
Turn Therapeutics Q1 EPS $(0.03) Misses $(0.02) Estimate

Turn Therapeutics (NASDAQ:TTRX) reported quarterly losses of $(0.03) per share which missed the analyst consensus estimate of $(0.02) by 50 percent. This is a 200 percent decrease over losses of $(0.01) per share from

Benzinga Newsdesk

PRO
Turn Therapeutics Q4 EPS $0.01

Turn Therapeutics (NASDAQ:TTRX) reported quarterly earnings of $0.01 per share.

Benzinga Newsdesk

PRO
Turn Therapeutics Q3 EPS $(0.07) vs $(0.03) Prior

Benzinga Newsdesk

Dow Dips Over 250 Points; Delta Air Lines Posts Upbeat Earnings

Avi Kapoor

Stock Market Today: S&P 500, Nasdaq Futures Slip As Fed Minutes Signal Tariff-Related Uncertainty—PepsiCo, Delta, Levi Strauss In Focus (UPDATED)

Editor’s Note: The future prices of benchmark tracking ETFs were updated in the story. U.S. stock futures fell on Thursday following Wednesday’s mixed close. Futures of major benchmark indices were lower.

Rishabh Mishra